CMP vs IPX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Compass Minerals presents a stark dichotomy between strong top-line growth and deteriorating fundamental health. The Piotroski F-Score of 2/9 indicates severe financial weakness, compounded by a high Debt/Equity ratio of 3.44. While the 1-year price performance is impressive (+103.1%) and the PEG ratio (0.12) suggests significant undervaluation relative to growth, the negative profit margins and poor historical earnings stability create a high-risk profile. The stock is currently trading near its analyst target price, leaving little room for immediate upside without a fundamental turnaround.
IPX exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor operational health. While the company maintains a strong liquidity position with a Current Ratio of 4.03 and very low debt (D/E 0.04), it is currently plagued by severe profitability issues, including an ROE of -50.42% and a negative forward P/E. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual deterministic data, which shows a bearish technical trend (0/100) and a sharp 6-month price decline of 41.3%.
Compare Another Pair
Related Comparisons
CMP vs IPX: Head-to-Head Comparison
This page compares Compass Minerals International, Inc. (CMP) and IperionX Limited (IPX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.